<DOC>
	<DOCNO>NCT01131468</DOCNO>
	<brief_summary>The purpose study determine whether N-acetylcysteine effective prevention hearing loss ear due aminoglycoside and/or vancomycine induce ototoxicity peritoneal dialysis patient .</brief_summary>
	<brief_title>Prevention Drug Induced Ototoxicity Peritoneal Dialysis Patients N-Acetylcysteine</brief_title>
	<detailed_description />
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Endstage renal disease Undergoing continuous ambulatory peritoneal dialysis renal replacement therapy Clinical diagnosis peritonitis episode continuous ambulatory peritoneal dialysis patient Developing first continuous ambulatory peritoneal dialysis relate peritonitis episode Being treat aminoglycoside antibiotic vancomycine within previous 3 month Detection mechanical occlusion external ear Having sign disturb integrity tympanic membrane otoscopy tympanometry History continuous ambulatory peritoneal dialysis relate peritonitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>ototoxicity</keyword>
	<keyword>aminoglycoside</keyword>
	<keyword>vancomycine</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>peritonitis</keyword>
</DOC>